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expansion, whereas neutrophil depletion is associated with a 
reduction in infarct size. Although the mechanism by which 
neutrophils produce this damage is unclear, it is possible that the 
reperfusion following prolonged ischemia may paradoxically lead 
to progressive leukocyte capillary plugging and the “no reflow” 
phenomenon.[4]
In the multinational, observational Global Registry of  Acute 
Coronary Events (GRACE) study, high admission leukocyte 
count was found to be an important independent predictor of  
in‑hospital mortality and the development of  heart failure for the 
entire spectrum of  acute coronary syndrome (ACS).[5]
In this journal issue, a study is published where the authors 
looked into the possibility of  combining both Thrombolysis 
in Myocardial Infarction (TIMI) risk score[6] and admission 
leukocyte count as an even better predictive tool for the adverse 
events of  cardiac failure and in‑hospital mortality among patients 
with STEMI. Echocardiogram was performed on all patients 
prior to discharge to determine the ejection fraction. Seventy 
patients were enrolled. High TIMI score is defined as a score of  
≥4 and high leukocyte count is defined as a count of  ≥10,000/ml. 
Heart failure is defined as an ejection fraction of  <50%.
In terms of  heart failure, the authors found that TIMI score alone 
has a sensitivity of  80% and a specificity of  95% of  identifying 
those with such complication, whereas leukocytosis (>10,000/ml) 
has a sensitivity of  82% and specificity of  85%. However, when 
combined together, it yields a sensitivity of  86% and specificity 
of  95% of  identifying heart failure.
Similarly, in terms of  in‑hospital mortality, TIMI score alone 
has a sensitivity of  80% and a specificity of  72% of  identifying 
those with a risk for in‑hospital mortality. On the other hand, 
leukocytosis alone yields a sensitivity of  60% and a specificity of  
58%. But when combined together, a sensitivity of  100% and a 
specificity of  73% were achieved.
Undoubtedly, the adage “time lost equals to myocardium lost” 
holds true in ST‑elevation myocardial infarction (STEMI) as it 
has been demonstrated that every minute of  delay to primary 
coronary angioplasty affects its 1‑year mortality.[1] Accordingly 
therefore, efforts must be made to minimize the delay for 
primary angioplasty. Unfortunately this challenge proves to be 
a formidable task particularly in centers without catheterization 
facilities. Referring every case of  STEMI for primary angioplasty 
is not only costly, but it is impractical and unnecessary. In many 
of  the cases presented less than three hours from the onset of  
symptoms, administering thrombolytics on‑site would be just 
as effective as primary angioplasty;[2] while in other cases such 
as those that are complicated with cardiogenic shock, a strategy 
for early revascularization is recommended.[3] As such, a risk 
stratification protocol using inexpensive, sensitive tools is very 
much needed particularly in centers without catheterization 
facilities and in those places where resources are scarce. This 
would allow those patients with high risk of  developing 
cardiogenic shock and in‑hospital mortality to be transferred, 
while those with low risk can be planned for shorter stay after 
medical stabilization.
High total leukocyte count on admission has been shown to 
be associated with increased risk of  developing heart failure 
and in‑hospital mortality in acute coronary syndrome. High 
neutrophil count is shown to be associated with infarct 
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Chew: Predicting post-STEMI compications using combined TIMI scores and leukocyte counts 
Although this study involved only 70 patients and encompassing 
only STEMI cases, I believe that the results from this study 
do appear promising. After all, in an economic downturn 
situation, high‑end technology and sophisticated equipments 
may not be the answer we are looking for; and even if  it 
does, it may not be affordable. On the other hand, simple, 
cost‑effective blood tests like the total leukocyte counts may 
just be what we need as a screening tool to prognosticate our 
patients.
Nonetheless, before one should consider using the combination 
of  TIMI score and leukocyte counts as a routine prognostication 
tool, several questions should be addressed. As elucidated by 
the authors, this study did not take into consideration a serial 
leukocyte count nor did it analyze the association of  different 
leukocyte counts with their relative risk of  developing adverse 
outcomes. It would be useful to know whether an incremental 
value of  admission leukocyte count is associated with an 
incremental risk of  developing such adverse outcomes. Perhaps 
a more extensive study with a larger sample size and one which 
encompasses the entire spectrum of  ACS, viz., unstable angina, 
non‑STEMI, and STEMI, could be carried out to look into 
the prospect of  using admission leukocyte count with TIMI 
as a combined set of  predictive tool for adverse outcomes 
following ACS. Perhaps, in the near future, a modified TIMI 
risk score with the inclusion of  admission leukocyte count as 
one of  their parameters could be developed as an even better 
predictive tool. In any case, such tool would definitely be 
beneficial in centers without catheterization facilities and early 
echocardiograhic assessment.
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